Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Androgen | 14 | 2021 | 1089 | 1.520 |
Why?
|
SOX9 Transcription Factor | 4 | 2013 | 145 | 0.930 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2012 | 317 | 0.740 |
Why?
|
Prostate | 5 | 2021 | 1765 | 0.590 |
Why?
|
High Mobility Group Proteins | 2 | 2008 | 179 | 0.550 |
Why?
|
Prostatic Neoplasms | 13 | 2021 | 11101 | 0.550 |
Why?
|
Mammary Neoplasms, Animal | 2 | 2018 | 123 | 0.530 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2018 | 8637 | 0.460 |
Why?
|
Trans-Activators | 3 | 2013 | 2857 | 0.440 |
Why?
|
Down-Regulation | 5 | 2013 | 2936 | 0.380 |
Why?
|
Doxycycline | 1 | 2012 | 348 | 0.350 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 325 | 0.340 |
Why?
|
Androgens | 7 | 2018 | 1281 | 0.340 |
Why?
|
Transcription Factors | 6 | 2013 | 12165 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2012 | 2456 | 0.270 |
Why?
|
Cell Line, Tumor | 16 | 2021 | 17128 | 0.270 |
Why?
|
G1 Phase | 1 | 2006 | 403 | 0.240 |
Why?
|
Mammary Glands, Animal | 2 | 2018 | 273 | 0.230 |
Why?
|
Cell Proliferation | 4 | 2013 | 10470 | 0.210 |
Why?
|
Neoplasm Transplantation | 5 | 2018 | 2014 | 0.200 |
Why?
|
Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2022 | 43 | 0.200 |
Why?
|
Cerebellar Cortex | 1 | 2022 | 108 | 0.190 |
Why?
|
p21-Activated Kinases | 3 | 2013 | 127 | 0.190 |
Why?
|
Ischemic Postconditioning | 1 | 2020 | 24 | 0.180 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3601 | 0.180 |
Why?
|
Mice, SCID | 4 | 2018 | 2627 | 0.170 |
Why?
|
beta Catenin | 4 | 2022 | 1047 | 0.160 |
Why?
|
Radioactive Pollutants | 1 | 2018 | 13 | 0.160 |
Why?
|
Chernobyl Nuclear Accident | 1 | 2018 | 15 | 0.160 |
Why?
|
Protein Phosphatase 1 | 2 | 2017 | 135 | 0.150 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2017 | 42 | 0.140 |
Why?
|
Wnt Proteins | 3 | 2013 | 724 | 0.140 |
Why?
|
Cell Growth Processes | 2 | 2008 | 381 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2021 | 756 | 0.130 |
Why?
|
Mice | 13 | 2022 | 82024 | 0.120 |
Why?
|
Phosphorylation | 5 | 2018 | 8314 | 0.120 |
Why?
|
Hospitals, Urban | 1 | 2017 | 496 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2018 | 542 | 0.120 |
Why?
|
Genes, Reporter | 1 | 2018 | 1526 | 0.110 |
Why?
|
Mice, Transgenic | 4 | 2018 | 9556 | 0.110 |
Why?
|
Mice, Inbred ICR | 2 | 2018 | 362 | 0.110 |
Why?
|
Myristic Acid | 1 | 2012 | 49 | 0.100 |
Why?
|
Transcription, Genetic | 3 | 2021 | 7612 | 0.100 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1157 | 0.100 |
Why?
|
Neoplasm Invasiveness | 2 | 2013 | 3618 | 0.100 |
Why?
|
Dihydrotestosterone | 1 | 2013 | 195 | 0.100 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 616 | 0.100 |
Why?
|
Enzyme Induction | 1 | 2012 | 455 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2013 | 21206 | 0.100 |
Why?
|
CDC2 Protein Kinase | 2 | 2017 | 212 | 0.100 |
Why?
|
Neural Pathways | 1 | 2022 | 3113 | 0.100 |
Why?
|
Animals | 14 | 2022 | 169222 | 0.090 |
Why?
|
Protein Kinase C-alpha | 1 | 2011 | 113 | 0.090 |
Why?
|
Operon | 1 | 2012 | 371 | 0.090 |
Why?
|
Mammary Glands, Human | 1 | 2013 | 202 | 0.090 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2013 | 434 | 0.090 |
Why?
|
RNA, Small Interfering | 3 | 2016 | 3428 | 0.090 |
Why?
|
Epithelial Cells | 4 | 2018 | 3703 | 0.090 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2080 | 0.090 |
Why?
|
Herpesvirus 4, Human | 1 | 2016 | 1082 | 0.090 |
Why?
|
Nerve Net | 1 | 2022 | 2352 | 0.090 |
Why?
|
Tyrosine | 2 | 2012 | 1427 | 0.080 |
Why?
|
Tosyl Compounds | 2 | 2008 | 115 | 0.080 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2428 | 0.080 |
Why?
|
Castration | 1 | 2009 | 149 | 0.080 |
Why?
|
Immediate-Early Proteins | 1 | 2011 | 444 | 0.080 |
Why?
|
Transgenes | 1 | 2012 | 1016 | 0.080 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2013 | 633 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2191 | 0.070 |
Why?
|
Male | 20 | 2022 | 364641 | 0.070 |
Why?
|
Anilides | 2 | 2008 | 413 | 0.070 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4904 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2016 | 2953 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2016 | 2846 | 0.070 |
Why?
|
Enhancer Elements, Genetic | 1 | 2013 | 1367 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4414 | 0.060 |
Why?
|
Enzyme Activation | 2 | 2013 | 3587 | 0.060 |
Why?
|
Neoplastic Stem Cells | 1 | 2013 | 1351 | 0.060 |
Why?
|
MAP Kinase Kinase 6 | 1 | 2004 | 20 | 0.060 |
Why?
|
Cell Line | 3 | 2021 | 15597 | 0.060 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11068 | 0.060 |
Why?
|
Signal Transduction | 7 | 2018 | 23642 | 0.060 |
Why?
|
Nitriles | 2 | 2008 | 980 | 0.060 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2013 | 1608 | 0.060 |
Why?
|
Transfection | 3 | 2008 | 5757 | 0.060 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3798 | 0.060 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 615 | 0.060 |
Why?
|
Neurons | 1 | 2022 | 9518 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13658 | 0.050 |
Why?
|
Humans | 25 | 2022 | 767991 | 0.050 |
Why?
|
Androgen Receptor Antagonists | 2 | 2017 | 123 | 0.050 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2011 | 2061 | 0.050 |
Why?
|
Cell Survival | 1 | 2011 | 5772 | 0.050 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 694 | 0.050 |
Why?
|
Autocrine Communication | 1 | 2022 | 168 | 0.050 |
Why?
|
Membrane Proteins | 1 | 2018 | 7876 | 0.050 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2022 | 687 | 0.050 |
Why?
|
Transcriptional Activation | 3 | 2017 | 1752 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4289 | 0.040 |
Why?
|
Keratin-8 | 1 | 2018 | 11 | 0.040 |
Why?
|
Space Perception | 1 | 2022 | 466 | 0.040 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2021 | 5335 | 0.040 |
Why?
|
Keratin-14 | 1 | 2018 | 57 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 4937 | 0.040 |
Why?
|
Androgen Antagonists | 3 | 2018 | 1412 | 0.040 |
Why?
|
Ukraine | 1 | 2018 | 151 | 0.040 |
Why?
|
Ligands | 2 | 2021 | 3284 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2630 | 0.040 |
Why?
|
Calreticulin | 1 | 2018 | 115 | 0.040 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 1327 | 0.040 |
Why?
|
Chromatin | 2 | 2021 | 2981 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6569 | 0.040 |
Why?
|
Receptors, Thrombopoietin | 1 | 2018 | 159 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3804 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2017 | 68 | 0.030 |
Why?
|
Cell Division | 2 | 2018 | 4473 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2884 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 1019 | 0.030 |
Why?
|
Medical Oncology | 1 | 2009 | 2341 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2006 | 2463 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2018 | 547 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2016 | 2392 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2018 | 663 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9521 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2017 | 202 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2830 | 0.030 |
Why?
|
Receptors, Complement 3d | 1 | 2016 | 117 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2018 | 930 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 561 | 0.030 |
Why?
|
Length of Stay | 2 | 2020 | 6495 | 0.030 |
Why?
|
Viral Matrix Proteins | 1 | 2016 | 193 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2020 | 1165 | 0.030 |
Why?
|
Feedback, Physiological | 1 | 2017 | 482 | 0.030 |
Why?
|
Gene Dosage | 1 | 2018 | 1211 | 0.030 |
Why?
|
Cell Movement | 2 | 2018 | 5209 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2018 | 1168 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8540 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 224 | 0.030 |
Why?
|
Cell Respiration | 1 | 2013 | 201 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1647 | 0.030 |
Why?
|
5-Methylcytosine | 1 | 2013 | 147 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2065 | 0.030 |
Why?
|
Adenine | 1 | 2018 | 995 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9493 | 0.030 |
Why?
|
In Situ Hybridization | 1 | 2016 | 1892 | 0.020 |
Why?
|
Cytosine | 1 | 2013 | 213 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2018 | 1777 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 874 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2429 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2016 | 1837 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2006 | 12797 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2013 | 451 | 0.020 |
Why?
|
China | 1 | 2017 | 2395 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2040 | 0.020 |
Why?
|
Protein Binding | 2 | 2018 | 9343 | 0.020 |
Why?
|
Antibodies | 1 | 2018 | 2421 | 0.020 |
Why?
|
Phospholipase C delta | 1 | 2009 | 7 | 0.020 |
Why?
|
Fibroblast Growth Factor 5 | 1 | 2009 | 9 | 0.020 |
Why?
|
Piperidines | 1 | 2018 | 1667 | 0.020 |
Why?
|
Genome-Wide Association Study | 1 | 2009 | 12795 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2009 | 16041 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 3514 | 0.020 |
Why?
|
Cytochrome P-450 CYP1A2 | 1 | 2009 | 68 | 0.020 |
Why?
|
Hippocampus | 1 | 2022 | 3786 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2018 | 2592 | 0.020 |
Why?
|
Propensity Score | 1 | 2017 | 1970 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6231 | 0.020 |
Why?
|
DNA, Viral | 1 | 2016 | 2201 | 0.020 |
Why?
|
Steroid 17-alpha-Hydroxylase | 1 | 2009 | 99 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2731 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1605 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6786 | 0.020 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2009 | 165 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.020 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2009 | 197 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8535 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2007 | 9412 | 0.020 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2009 | 276 | 0.020 |
Why?
|
Pyrazoles | 1 | 2018 | 2028 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2013 | 1676 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1805 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4648 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 22365 | 0.020 |
Why?
|
Female | 5 | 2020 | 397113 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5798 | 0.020 |
Why?
|
Systole | 1 | 2009 | 937 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2013 | 4525 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 785 | 0.020 |
Why?
|
Phosphoserine | 1 | 2006 | 204 | 0.020 |
Why?
|
Pyrimidines | 1 | 2018 | 3046 | 0.020 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2008 | 409 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2009 | 818 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6843 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2013 | 2149 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2008 | 468 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9666 | 0.010 |
Why?
|
DNA | 1 | 2018 | 7213 | 0.010 |
Why?
|
Mutation | 1 | 2009 | 30211 | 0.010 |
Why?
|
Cyproterone Acetate | 1 | 2003 | 5 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15660 | 0.010 |
Why?
|
Purines | 1 | 2006 | 615 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2017 | 5349 | 0.010 |
Why?
|
TCF Transcription Factors | 1 | 2003 | 138 | 0.010 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2003 | 152 | 0.010 |
Why?
|
Adult | 3 | 2018 | 223583 | 0.010 |
Why?
|
India | 1 | 2009 | 2334 | 0.010 |
Why?
|
Europe | 1 | 2009 | 3437 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12828 | 0.010 |
Why?
|
Aged | 3 | 2020 | 171446 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3414 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 60048 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8377 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4618 | 0.010 |
Why?
|
Serine | 1 | 2004 | 831 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19017 | 0.010 |
Why?
|
Middle Aged | 3 | 2020 | 223422 | 0.010 |
Why?
|
Prevalence | 1 | 2017 | 15867 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2889 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2600 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2906 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11665 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 3771 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24314 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6119 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40214 | 0.010 |
Why?
|
Proteins | 1 | 2009 | 6009 | 0.010 |
Why?
|
Genetic Variation | 1 | 2009 | 6611 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9614 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 65364 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2006 | 5694 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74936 | 0.010 |
Why?
|
Kidney | 1 | 2004 | 7065 | 0.010 |
Why?
|
United States | 1 | 2017 | 73027 | 0.000 |
Why?
|
Adolescent | 1 | 2017 | 89155 | 0.000 |
Why?
|